Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 4,087,703
- Share change
- -674,016
- Total reported value
- $14,838,993
- Put/Call ratio
- 157%
- Price per share
- $3.63
- Number of holders
- 22
- Value change
- -$3,209,332
- Number of buys
- 9
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365A309:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
2,414,487
|
$9,416,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.61%
|
490,334
|
$1,898,000 | — | 30 Sep 2020 | |
| Psagot Value Holdings Ltd. |
13F
|
Company |
0.59%
|
470,255
|
$1,820,000 | — | 30 Sep 2020 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.37%
|
300,000
|
$1,161,000 | — | 30 Sep 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
212,591
|
$823,000 | — | 30 Sep 2020 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.25%
|
204,355
|
$751,000 | — | 30 Sep 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.2%
|
161,220
|
$605,000 | — | 30 Sep 2020 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
149,151
|
$577,000 | — | 30 Sep 2020 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.13%
|
101,768
|
$397,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
66,631
|
$258,000 | — | 30 Sep 2020 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.06%
|
45,853
|
$177,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
44,679
|
$173,000 | — | 30 Sep 2020 | |
| Measured Wealth Private Client Group, LLC |
13F
|
Company |
0.05%
|
38,116
|
$148,000 | — | 30 Sep 2020 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
18,043
|
$69,000 | — | 30 Sep 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
14,661
|
$57,000 | — | 30 Sep 2020 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.01%
|
9,096
|
$35,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
6,284
|
$24,000 | — | 30 Sep 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$22,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,512
|
$17,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,100
|
$8,000 | — | 30 Sep 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$4,257 | — | 30 Sep 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
500
|
$2,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
222
|
$1,000 | — | 30 Sep 2020 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2020
As of 31 Dec 2020,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,087,703 shares.
The largest 10 holders included
Burrage Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GROUP ONE TRADING, L.P., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and JANE STREET GROUP, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
23
Q4 2020 holders
22
Holder diff
-1
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.